NEW YORK–(BUSINESS WIRE)–Warby Parker Inc. (NYSE: WRBY) a direct-to-consumer lifestyle brand focused on vision for all, today announced that the Company will be presenting at the Cowen 6th Annual Future of the Consumer Conference on Wednesday, May 25…
Category: Business
Aerie Pharmaceuticals Announces First Participant Dosed in the Phase 3 Registrational COMET-2 Study of AR-15512 for the Treatment of Dry Eye Disease
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), a pharmaceutical company focused on the discovery, development, and commercialization of first-in-class ophthalmic therapies, today announced that the first participant has been…
Aldeyra Therapeutics Designates Schirmer Test as Sole Primary Endpoint in Phase 3 TRANQUILITY-2 Trial of Reproxalap in Dry Eye Disease
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced the designation of Schirmer test, a measure of tear production, as the sole primary endpoint in the Phase 3 TRANQUILITY-2 clinical trial of reproxala…
Aldeyra Therapeutics to Present at H.C. Wainwright Global Investment Conference
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company developing innovative therapies for the treatment of immune-mediated diseases, today announced that Todd C. Brady, M.D., Ph.D., President an…
The Art of the Brick and EnChroma Offer Color Blind Dads a Memorable, Colorful Father’s Day Experience
CHICAGO & SAN FRANCISCO–(BUSINESS WIRE)– #artofthebrick–Art of the Brick exhibit offering EnChroma glasses so color blind dads can see colors at SF & Museum of Science Industry Chicago shows on Fathers Day
Alcon to Acquire EYSUVIS Adding to Its Ophthalmic Eye Drop Portfolio
GENEVA–(BUSINESS WIRE)–Alcon to Acquire EYSUVIS Adding to Its Ophthalmic Eye Drop Portfolio
Global Optical Coherence Tomography Angiography Equipment Market to 2028 – COVID-19 Impact and Analysis – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Optical Coherence Tomography Angiography Equipment Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Type and End User” report has been added to ResearchAndMarkets.com’s offering. The optical coherence tomog…
Glaukos Announces Participation in the Piper Sandler Virtual Ophthalmology Symposium
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that …
Grant From Research to Prevent Blindness and Castle Biosciences Supports Medical Student Research in Ocular Cancer
NEW YORK & FRIENDSWOOD, Texas–(BUSINESS WIRE)—- $CSTL #CSTL–Research to Prevent Blindness and Castle are partnering to increase opportunities for medical students to gain research experiences in ocular cancer.
Steven C. Glass Named Medical Mutual’s Next CEO and President
CLEVELAND–(BUSINESS WIRE)–Bob King, Lead Director of Medical Mutual’s board of directors, today announced that Steven (Steve) C. Glass will succeed Rick Chiricosta as CEO and President of Medical Mutual of Ohio. Mr. Glass will also take a seat on Med…
Aldeyra Therapeutics Announces that Post-Hoc Analysis Using Computer Automated Grading of Phase 3 TRANQUILITY Trial Digital Photography Demonstrated Statistical Significance in Favor of Reproxalap Over Vehicle for Primary Endpoint of Ocular Redness
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today reported that a post-hoc analysis using computer automated grading of digital photography from the completed Phase 3 TRANQUILITY dry eye chamber trial demonstr…
Qlaris Bio Reports Phase 2 Clinical Trial Results Demonstrating Favorable Safety and Tolerability Profile and Positive Efficacy Signal for QLS-101
WELLESLEY, Mass.–(BUSINESS WIRE)–Qlaris Bio, Inc. (the “Company” or “Qlaris”), a biotechnology company targeting high unmet needs in debilitating ophthalmic diseases, today announced results from QC-201, a first-in-human, Phase 2 clinical trial of QL…
Riassunto: Il Regno Unito è il primo paese a concedere una licenza per il biosimilare oftalmico di Teva, Ongavia (ranibizumab)▼
AMSTERDAM–(BUSINESS WIRE)–Teva Pharmaceutical Industries Ltd valuta favorevolmente la decisione dell’Agenzia dei medicinali e dei prodotti sanitari del Regno Unito (MHRA) di concedere una licenza per Ongavia®, un biosimilare di Lucentis® (ranibizumab…
Première licence accordée au Royaume-Uni pour le biosimilaire ophtalmologique de Teva, Ongavia (ranibizumab)▼
AMSTERDAM–(BUSINESS WIRE)–Teva Pharmaceutical Industries Ltd se réjouit de la décision de l’Agence britannique de réglementation des médicaments et des soins de santé (MHRA) de délivrer une licence pour Ongavia®, un biosimilaire à injection oculaire …
Großbritannien erteilt als erstes Land eine Zulassung für das ophthalmologische Biosimilar Ongavia (Ranibizumab) von Teva▼
AMSTERDAM–(BUSINESS WIRE)–Teva Pharmaceutical Industries Ltd. begrüßt die Entscheidung der britischen medizinischen Zulassungs- und Aufsichtsbehörde für Arzneimittel (Medicines & Healthcare Regulatory Agency, MHRA), eine Lizenz für Ongavia®, ein …
Sunvera Group Forms New Partnership With William S. Goldstein, MD PC – Laser Eye Care Center
BINGHAM FARMS, Mich.–(BUSINESS WIRE)–Sunvera Group has formed a new partnership with William S. Goldstein, MD PC in Shelby Township, expanding their network across Michigan and Ohio.
Iveric Bio to Participate in the H.C. Wainwright Global Investment Conference
PARSIPPANY, N.J.–(BUSINESS WIRE)–Iveric Bio announced that Pravin U. Dugel, M.D., President, will present a corporate overview at the H.C. Wainwright Global Investment Conference.
Warby Parker Announces First Quarter 2022 Results
NEW YORK–(BUSINESS WIRE)–Warby Parker Inc. (NYSE: WRBY) (the “Company”), a direct-to-consumer lifestyle brand focused on vision for all, today announced financial results for the first quarter ended March 31, 2022. “Our team has a lot to be proud of …
Worldwide Polyclinics Industry to 2027 – Focus on Large Scale Polyclinic v/s Express Clinics – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Polyclinics Market, By Type (Large Scale Polyclinic v/s Express Clinic), By Services (Diagnostic, Consultation, Treatment), By Therapy Area, By Region, Competition Forecast and Opportunities, 2017-2027” report has b…
Global Spectacle Lens Market Report to 2030 – Featuring Carl Zeiss Meditec, Cooper Companies and Essilor International Among Others – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Spectacle Lens Market, By Type, By Material, By Coatings, By Application, By Distribution Channel, Estimation & Forecast, 2017 – 2030” report has been added to ResearchAndMarkets.com’s offering. The global Spect…